financetom
Business
financetom
/
Business
/
Texas Capital Bancshares Q1 Earnings, Revenue Drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Texas Capital Bancshares Q1 Earnings, Revenue Drop
Apr 18, 2024 4:09 AM

06:58 AM EDT, 04/18/2024 (MT Newswires) -- Texas Capital Bancshares ( TCBI ) reported Q1 earnings Thursday of $0.46 per diluted share, down from $0.70 a year earlier.

Analysts polled by Capital IQ expected $0.58.

Revenue for the quarter ended March 31, expressed as the sum of net interest income and total noninterest income, was $256.3 million, down from $272.7 million a year earlier.

Analysts surveyed by Capital IQ expected $253.1 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
The Arena Group Acquires ShopHQ, Expanding into Data Syndication, E-Commerce and Social Selling
The Arena Group Acquires ShopHQ, Expanding into Data Syndication, E-Commerce and Social Selling
Oct 17, 2025
NEW YORK--(BUSINESS WIRE)-- The Arena Group Holdings, Inc. ( AREN ) (“The Arena Group” or the “Company”), has acquired the intellectual property of ShopHQ from IV Media, LLC. The Arena Group ( AREN ) plans to build on the legacy of the 35-year-old brand with a primary focus on E-Commerce and interactive selling. “With the acquisition of ShopHQ, a former...
Summit Therapeutics Expands Phase III Ivonescimab Program Into Colorectal Cancer
Summit Therapeutics Expands Phase III Ivonescimab Program Into Colorectal Cancer
Oct 17, 2025
08:29 AM EDT, 10/17/2025 (MT Newswires) -- Summit Therapeutics ( SMMT ) said Friday it is initiating a phase III trial to evaluate bispecific antibody ivonescimab as a first line therapy in patients with unresectable metastatic colorectal cancer. The biopharmaceutical company said the trial represents a first global study of ivonescimab beyond non-small cell lung cancer. The phase III trial...
Meta Platforms Adds Parental Controls for AI Characters
Meta Platforms Adds Parental Controls for AI Characters
Oct 17, 2025
08:28 AM EDT, 10/17/2025 (MT Newswires) -- Meta Platforms ( META ) said Friday that it is providing simple, new ways for parents to control how much interaction their children have with artificial intelligence characters. The company said the new features will allow parents to block their kids' access to one-on-one chats with AI characters entirely, or just block specific...
Taoping Signs Letter of Intent to Acquire Alphalion Holding, Significantly Bolsters AI-Driven Digital Ecosystem
Taoping Signs Letter of Intent to Acquire Alphalion Holding, Significantly Bolsters AI-Driven Digital Ecosystem
Oct 17, 2025
SHENZHEN, China, Oct. 17, 2025 /PRNewswire/ -- Taoping Inc. ( TAOP ) , a provider of innovative smart cloud platform services and solutions, today announced that it has entered into a non-binding Letter of Intent (LOI) with the shareholders of Alphalion Holding Limited (Alphalion Holding) to acquire 100% of its equity interests. The proposed acquisition remains subject to the completion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved